$INO Company News Monday's biggest gaining and

New Post Public Reply Private Reply Replies (0) Message Board

Jul 21, 2014 at 12:48 PM

$INO Company News

Monday's biggest gaining and declining stocks 5:45 p.m. Nov. 30, 2009 - MarketWatch
Inovio, Merck gain; Novavax falls 5:26 p.m. Nov. 20, 2009 - Val Brickates Kennedy
Friday's biggest gaining and declining stocks 5:25 p.m. Nov. 20, 2009 - MarketWatch
Onyx, Charles River lead drug stocks lower 12:31 p.m. Aug. 5, 2009 - Val Brickates Kennedy
Mylan, Merck, Bayer lead drug stocks higher 10:35 a.m. July 30, 2009 - Val Brickates Kennedy
Drug stocks retreat as Bayer, Inovio jump 11:31 a.m. July 29, 2009 - Val Brickates Kennedy
Inovio to raise $16.2 million from share sale 6:12 a.m. May 16, 2007 - Simon Kennedy
Inovio to sell 4.59 shjares of unit at $3.52 a share 6:06 a.m. May 16, 2007 - Sarah Turner
Monday's biggest stock gainers and decliners 5:07 p.m. March 26, 2007 - MarketWatch
Inovio: DNA delivery technology lifts HIV vaccine potency 6:23 a.m. March 26, 2007 - Sarah Turner
Innovio: DNA delivery technology lifts HIV vaccine potency 6:06 a.m. March 26, 2007 - Steve Goldstein
Inovio Biomedical started at average at Caris & Co. 10:11 a.m. June 2, 2006 - Tomi Kilgore
Inovio study shows benefit of tumor ablation therapy 7:08 a.m. Nov. 18, 2005 - Aude Lagorce
Inovio: Study shows benefit of tumor ablation therapy 7:01 a.m. Nov. 18, 2005 - Steve Goldstein
Updates, advisories and surprises 10:01 p.m. July 13, 2005 - MarketWatch
Inovio receives $2M milestone payment from Merck 6:41 a.m. July 13, 2005 - Kabir Chibber
Inovio Biomedical to get $2M milestone from Merck 6:17 a.m. July 13, 2005 - Steve Goldstein
Inovio to receive option fee, possible milestones 6:06 a.m. May 12, 2005 - Steve Goldstein
Merck exercises option on Inovio antigen deal 6:05 a.m. May 12, 2005 - Steve Goldstein

Biggest Movers in Healthcare Stocks Now – NPSP INO IRWD GILD 8:00 a.m. July 18, 2014 - InvestorPlace.com
Biotech Stock Mailbag: MannKind, Bluebird, Northwest Bio, More '14 Tradable Biotech Events 9:30 a.m. July 14, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – AUXL OPK ARIA MNKD 1:30 p.m. July 11, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – CNC GSK LCI CLVS 6:45 a.m. July 10, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – INO PRXL LCI INCY 2:00 p.m. July 7, 2014 - InvestorPlace.com
4 Biotech Stocks With Big Money Coming In 2:50 p.m. June 30, 2014 - benzinga.com
Hottest Healthcare Stocks Now – MNKD INO ACAD INCY 8:00 a.m. June 30, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – TARO PCRX FMS INO 8:30 a.m. June 27, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – FMS AUXL INO VRX 7:45 a.m. June 26, 2014 - InvestorPlace.com
Did Short Sellers In Inovio Listen To The Wrong Piper? 11:17 a.m. June 23, 2014 - Seeking Alpha
Inovio Price Volatility: Market-Naive Moves By Management And Confusion Over Scientific Issues 11:24 a.m. June 18, 2014 - Seeking Alpha
Inovio responds to Mr. Feuerstein's article 10:17 a.m. June 11, 2014 - Seeking Alpha
Inovio Pharmaceuticals (INO) Marked As A Dead Cat Bounce Stock 9:45 a.m. June 11, 2014 - TheStreet.com
Inovio Pharmaceuticals (INO) Falls: Stock Plunges 13.4% - Tale of the Tape 8:50 a.m. June 11, 2014 - Zacks.com
Why Inovio Pharmaceuticals (INO) Stock Rose, Then Plunged Today (Update) 4:24 p.m. June 10, 2014 - TheStreet.com
Ugly reversal for Inovio 3:55 p.m. June 10, 2014 - Seeking Alpha
Perilous Reversal Stock: Inovio Pharmaceuticals (INO) 1:01 p.m. June 10, 2014 - TheStreet.com
Inovio CEO Preps Retail Investors for Drug Study Failure 12:23 p.m. June 10, 2014 - TheStreet.com
Strength Seen in Inovio (INO): Stock Rises 9.4% - Tale of the Tape 9:46 a.m. June 10, 2014 - Zacks.com
Too Many Pending Milestones For Me To Sell Inovio 12:35 p.m. June 9, 2014 - Seeking Alpha

Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Added To Russell Global, Russell 2000® and Russell Microcap® Indexes 4:00 a.m. July 1, 2014 - PR Newswire - PRF
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Initiates Cervical Cancer Clinical Trial 4:00 a.m. June 23, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Broadens its Intellectual Property Portfolio from the University of Pennsylvania 4:00 a.m. June 17, 2014 - PR Newswire - PRF
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties 8:04 a.m. June 16, 2014 - ACCESSWIRE
Inovio Pharmaceuticals to Present at Upcoming Healthcare Conferences 4:00 a.m. June 16, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Clarifies Facts of its VGX-3100 Phase II Trial and Immunotherapy Technology 9:00 a.m. June 11, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Initiates Immune Therapy Trial for Head & Neck Cancer Caused by HPV 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Announces Reverse Stock Split Date 4:00 a.m. May 30, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Breakthrough DNA-Based Monoclonal Antibody Therapy Completely Protects Animals From Lethal Viral Challenge 4:00 a.m. May 27, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Subsidiary Sells Animal Health Assets 4:00 a.m. May 27, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Announces 1 For 4 Reverse Split 4:00 a.m. May 23, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference 4:00 a.m. May 21, 2014 - PR Newswire - PRF
Pre-Market Pulse on Top Gainers -- Research on Inovio Pharma, Novavax, FreeSeas, and ImmunoCellular Therapeutics 11:05 a.m. May 20, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis 4:00 a.m. May 13, 2014 - PR Newswire - PRF
Active Stocks Pre-Market Notes -- Research on Johnson Controls, EXCO Resources, Inovio Pharma, and US Bancorp. 1:18 p.m. April 29, 2014 - PR Newswire - PRF
Active Stocks Coverage -- Research on Mallinckrodt, American Eagle Outfitters, Blackstone, and Inovio Pharma 1:01 p.m. April 8, 2014 - PR Newswire - PRF
Healthcare Companies Announce Awards, Partnerships, Milestone Payments, and Conference Schedules - Analyst Notes on Inovio, LifePoint, Mallinckrodt, Ligand, and Theravance 8:00 a.m. April 2, 2014 - PR Newswire - PRF
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality 4:00 a.m. April 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

SoftwareOne Triumphs in 2026 GitHub Partner Awards

SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...

AppLovin Faces Class Action: AI Growth Claims Under Fire

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

HERVolution's HERV-K Antigens: A Cancer Breakthrough?

Digging into HERVolution's Game-Changing Data Picture HERVolution in the spotlight, rolling out data that could shake up our approach to cancer immunotherapy. The big headline? HERV-K antigens might just be the whistle-blower we've been looking for to get the immune system off the bench and onto the field. How's that for a kick in the conventional wisdom of cancer...

QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Faith on Trial: La Luz del Mundo Faces Court Ruling

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

Corgi Insurance Eyes $100B Auto Market with New Launch

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Pave and Levels.fyi Unite: Revolutionize Pay Decisions

Diving straight into the heart of it, here's a move in the business world that's all but marking its territory on the compensation landscape. Pave, already a big player in agentic compensation management, is shaking hands with Levels.fyi, a platform prized for its real-deal compensation data detailed down to the company, level, location, and skill. These folks are...

Honeywell Aerospace Posts Solid Q3, Raises Guidance

Honeywell Aerospace Surprises with Strong Third Quarter In a world where numbers are often as slippery as a greased pig, Honeywell Aerospace (NASDAQ:HONA) has managed to pin down a surprisingly robust third quarter. Let’s break it down: they’ve claimed sales of a cool $4.6 billion, reflecting a 2% bump both in reported and organic revenue from the previous year, and...